Tectonic Therapeutic | AVRO - Operating Profit


Tectonic Therapeutic reported $-27.3M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alnylam Pharmaceuticals USD 112.6M 24.99M Jun/2026
Celltrion KRW 12.9B 822.77M Mar/2026
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Deva Holding AS TRY 964.87M 240.32M Sep/2023
Dianthus Therapeutics USD -46.53M 23.01M Mar/2026
Divis Laboratories Ltd INR 11.29B 3.15B Jun/2026
Gilead Sciences USD 3.85B 1.17B Jun/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
Kangmei Pharma CNY -10.94M 15.75M Mar/2026
Karyopharm Therapeutics USD -26.76M 8.92M Mar/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
MacroGenics USD -33.44M 21.34M Mar/2026
Malin Corporation EUR -1.1M 400K Dec/2024
Medical Developments International AUD -36K 444K Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Organigram Holdings CAD -9.79M 10.33M Mar/2026
Ovoca Bio EUR -173K 990K Dec/2025
Pfizer USD 667M 4.32B Jun/2026
Pharma Mar EUR -1.4M 2.03M Jun/2026
Qiagen NV USD 141.4M 24.77M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sangamo BioSciences USD -33.51M 12.77M Jun/2024
Sanofi EUR 2.38B 449M Jun/2026
Sarepta Therapeutics USD 13.29M 345.14M Jun/2026
Sartorius EUR 164M 3.3M Jun/2026
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Takeda JPY 201.42B 215.04B Jun/2026
Tilray USD -20.01M 9.34M Sep/2025
Zealand Pharma A/S -539M 168.05M Mar/2026
Zz Pientze Pharmaceu CNY 837.81M 336.48M Mar/2026